BIXOLON Showcases the Latest in Logistics Printing at Intralogistica 2022
Intralogistica – (03.05-06.05.2022, Milan, Italy) BIXOLON, the global manufacturer of advanced Receipt, Label and Mobile…
News
UKCloud to secure the UK’s sovereign digital future, powered by VMware’s latest technologies
UKCloud is expanding its support for the newest VMware multi-cloud and app modernisation innovations, solidifying…
AB Science announced the continuation of the Phase 2 study evaluating masitinib in combination with isoquercetin in COVID-19, following the recommendation of the Data and Safety Monitoring Board (DSMB)
PRESS RELEASE POSITIVE RECOMMENDATION OF THE DATA AND SAFETY MONITORING BOARD TO CONTINUE THE PHASE…
OMass Therapeutics Raises $100 Million in Series B Financing to Progress Drug Pipeline in Immunology and Rare Diseases
PRESS RELEASE OMass Therapeutics Raises $100 Million in Series B Financing to Progress Drug Pipeline…
Immunicum AB: Immunicum Publishes Phase II MERECA Trial Results of Ilixadencel in Kidney Cancer in European Urology Open Sciences
Immunicum AB (“Immunicum” publ; IMMU.ST), a biopharmaceutical company focused on therapies addressing tumor recurrence and…
Nicox Reports 2021 Financial Results and First Quarter 2022 Financial Highlights and Provides Update on Key Programs and Milestones
Press Release Nicox Reports 2021 Financial Results and First Quarter 2022 Financial Highlights and Provides…
Press Release: Sanofi continues to deliver strong business EPS growth driven by higher sales and improved margins in Q1
Sanofi continues to deliver strong business EPS(1) growth driven by higher sales and improved margins…
Press Release: Sanofi continues to deliver strong business EPS growth driven by higher sales and improved margins in Q1
Sanofi continues to deliver strong business EPS(1) growth driven by higher sales and improved margins…
Kapruvia® approved by European Commission for the treatment of moderate-to-severe pruritus in hemodialysis patients
First approved therapy in Europe for the treatment of chronic kidney disease (CKD)-associated pruritus in…
Addex to Present at the Swiss Biotech Day 2022
Geneva, Switzerland, April 28, 2022 – Addex Therapeutics Ltd (SIX: ADXN, Nasdaq: ADXN), a clinical-stage pharmaceutical…
argenx to Report First Quarter 2022 Financial Results and Business Update on May 5, 2022
April 28, 2022 Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology…
Malaysian Genomics Resource Centre Berhad Supports Yayasan Seri Negara’s Ramadhan Initiative
PETALING JAYA, Malaysia, Apr 28, 2022 – (ACN Newswire) – Malaysian Genomics Resource Centre Berhad…
Fundamental Labs Adds Facebook Veteran To Deepen Its Gaming Investments
AUSTIN, Texas–(BUSINESS WIRE)–Fundamental Labs, a blockchain and digital asset focused venture capital firm, has announced…
AiM Future Joins the Edge AI and Vision Alliance
The company will demonstrate its edge AI accelerator and software technologies at the upcoming Embedded…
Dante Labs selected to provide genetic testing for Abu Dhabi Stem Cells Center, jointly developing mRNA cancer vaccines
ADSCC and Dante Labs sign agreement Dr. Yendry Ventura Carmenate, General Manager at Abu Dhabi…
CORRECTING and REPLACING — Affimed N.V.
In a press release issued earlier today by Affimed N.V. (Nasdaq: AFMD), please note that…
Sio Gene Therapies Provides Corporate Update
-Company Announces Termination of Licensing Agreement for GM1 and GM2 Gene Therapies with the University…
Surface Oncology to Present Clinical Update on SRF388 at American Society of Clinical Oncology Annual Meeting
CAMBRIDGE, Mass., April 27, 2022 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company…
AnaptysBio Announces Positive ANB032 (anti-BTLA agonist) Top-Line Phase 1 Data and Provides Pipeline Updates
ANB032, our wholly owned anti-BTLA agonist antibody, demonstrated favorable safety, tolerability and a rapid and sustained…
Statera Biopharma and Immune Therapeutics Inc. Announce Strategic Agreement for Rights to Low Dose Naltrexone
FORT COLLINS, Colo., April 27, 2022 (GLOBE NEWSWIRE) — Statera Biopharma (Nasdaq: STAB) (the “Company”),…